Overview Assessing Cosopt Switch Patients Status: Completed Trial end date: 2007-04-01 Target enrollment: Participant gender: Summary To assess the safety and efficacy of a cohort of patients switched to the dorzolamide/timolol maleate fixed combination because they are insufficiently controlled on latanoprost monotherapy. Phase: Phase 4 Details Lead Sponsor: Pharmaceutical Research NetworkTreatments: DorzolamideMaleic acidTimolol